ANDROGEN RECEPTOR SIGNALING REDUCES DIRECT CYTOTOXICITY OF BACILLUS CALMETTE-GUERIN (BCG) IN BLADDER CANCER CELLS VIA MODULATING RAB27B

被引：0
|
作者：
Mizushima, Taichi
Jiang, Guiyang
Kawahara, Takashi
Li, Peng
Han, Bin
Inoue, Satoshi
Ide, Hiroki
Jalalizadeh, Mehrsa
Uemura, Hiroji
Reis, Leonardo
Miyamoto, Hiroshi
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 201卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP57-08
引用
收藏
页码：E815 / E816
页数：2
相关论文
共 40 条
  • [1] Androgen Receptor Signaling Reduces the Efficacy of Bacillus Calmette-Guerin Therapy for Bladder Cancer via Modulating Rab27b-Induced Exocytosis
    Mizushima, Taichi
    Jiang, Guiyang
    Kawahara, Takashi
    Li, Peng
    Han, Bin
    Inoue, Satoshi
    Ide, Hiroki
    Kato, Ikuma
    Jalalizadeh, Mehrsa
    Miyagi, Etsuko
    Fukuda, Mitsunori
    Reis, Leonardo O.
    Miyamoto, Hiroshi
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (09) : 1930 - 1942
  • [2] ANDROGEN RECEPTOR ACTIVITY MODULATES DIRECT CYTOTOXICITY OF BACILLUS CALMETTE-GUERIN (BCG) IN BLADDER CANCER CELLS
    Chen, Jinbo
    Li, Peng
    Mizushima, Taichi
    Han, Bin
    Inoue, Satoshi
    Ide, Hiroki
    Jalalizadeh, Mehrsa
    Reis, Leonardo
    Miyamoto, Hiroshi
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1177 - E1177
  • [3] Immunohistochemistry of Androgen Receptor and Rab27b in Non-Muscle-Invasive Bladder Cancer as Predictors of Sensitivity to Intravesical Bacillus Calmette-Guerin Immunotherapy
    Mizushima, Taichi
    Kawahara, Takashi
    Kato, Ikuma
    Jiang, Guiyang
    Miyamoto, Hiroshi
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 937 - 937
  • [4] Immunohistochemistry of Androgen Receptor and Rab27b in Non-Muscle-Invasive Bladder Cancer as Predictors of Sensitivity to Intravesical Bacillus Calmette-Guerin Immunotherapy
    Mizushima, Taichi
    Kawahara, Takashi
    Kato, Ikuma
    Jiang, Guiyang
    Miyamoto, Hiroshi
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 937 - 937
  • [5] The role of mast cells and eosinophils in bladder cancer and Bacillus Calmette-Guerin (BCG) treatment
    Zaffran, Ilan
    Zoabi, Yara
    Gaur, Pratibha
    Alekberli, Fidan Rahimli
    Yutkin, Vladimir
    Schaffer, Francesca Levi
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 761 - 761
  • [6] Modulating the immune response to Bacillus Calmette-Guerin (BCG): a novel way to increase the immunotherapeutic effect of BCG for treatment of bladder cancer?
    Sapre, Nikhil
    Corcoran, Niall M.
    BJU INTERNATIONAL, 2013, 112 (06) : 852 - 853
  • [7] Effects of Bacillus Calmette-Guerin (BCG) and interferon α-2b on superficial bladder cancer.
    Zhang, Y
    Khoo, HE
    Gan, YH
    Mahendran, R
    Esuvaranathan, K
    CLINICAL CANCER RESEARCH, 1999, 5 : 3807S - 3807S
  • [8] Human β-defensin 2 may inhibit internalisation of bacillus Calmette-Guerin (BCG) in bladder cancer cells
    Kim, Jung Hoon
    Kim, Soon-Ja
    Lee, Kyung Mee
    Chang, In Ho
    BJU INTERNATIONAL, 2013, 112 (06) : 781 - 790
  • [9] Bacillus Calmette-Guerin and BCG Cell Wall Skeleton Suppressed Viability of Bladder Cancer Cells In Vitro
    Kato, Tomoyuki
    Bilim, Vladimir
    Yuuki, Kaori
    Naito, Sei
    Yamanobe, Takuya
    Nagaoka, Akira
    Yano, Ikuya
    Akaza, Hideyuki
    Tomita, Yoshihiko
    ANTICANCER RESEARCH, 2010, 30 (10) : 4089 - 4096
  • [10] Interleukin-10 inhibits the induction of macrophage cytotoxicity against bladder cancer cells by Mycobacterium bovis bacillus Calmette-Guerin (BCG)
    Luo, Yi
    Han, Ruifa
    Evanoff, David P.
    Chen, Xiaohong
    CANCER RESEARCH, 2010, 70
1234